m.balogun
TL2 · Coimbra
Contributes reviews on supplier material. Based in Coimbra.
Joined 1 May 2025 · last posted 4d · groups: regional-apac
96Posts here
2Topics
0Solutions
726Likes received
375Likes given
22Badges
173Days visited
2.5kPosts read
Recent activity
Full stream-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #105 · Access › International · 24 Jul 2026 · 0 likes Where a jurisdiction has published guidance for clinicians, that document usually answers the practical questions better than any consumer-facing page.
-
Packaging that arrived damaged: documenting it properly Replied, post #44 · Sourcing › Logistics · 17 Jul 2026 · 10 likes Post #42 answers the question as asked. The question underneath it is different. Split shipments reduce single-point risk and increase the number of transits. Which…
-
Follow-up: Signs of dehydration worth acting on Replied, post #28 · Safety › Adverse events · 17 Jul 2026 · 27 likes On post #24 — agreed on the reasoning, with one qualification. Reporting here and reporting to a national scheme are not alternatives. The second is what feeds safety…
-
Follow-up: Reading an interaction checker output critically Replied, post #49 · Practice › Interactions · 16 Jul 2026 · 5 likes Insulin interaction: semaglutide and tirzepatide are not contraindicated with insulin but the combination carries hypoglycemia risk if insulin doses are not adjusted.…
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #21 · Sourcing › Regulatory · 14 Jul 2026 · 12 likes Right — I had this wrong and I am glad to have read it before it mattered.
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #58 · Compounds › Retatrutide · 13 Jul 2026 · 0 likes An observation about retatrutide discussion that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than…
-
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #112 · Evidence › Journal club · 6 Jul 2026 · 9 likes Picking up post #109: that is the part I would want checked first. A definition problem is doing most of the work in this orforglipron phase 2 discussion. Once the term…
-
Submitting a sample: the process end to end Replied, post #55 · Sourcing › Independent verification · 3 Jul 2026 · 14 likes Submitting a sample would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Constipation management, with a dietitian's contribution Replied, post #81 · Practice › Side effects · 19 Jun 2026 · 4 likes What I would want before treating constipation management as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #106 · Practice › Storage & stability · 9 Jun 2026 · 10 likes Bookmarking this. I will come back when I have something worth adding.
-
Electrolyte supplements: which ones do anything Replied, post #21 · Nutrition & Training › Hydration & electrolytes · 2 Jun 2026 · 0 likes Reduced intake reduces electrolyte intake alongside everything else, which is the mechanism behind most of what gets attributed to the compound here.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #51 · Practice › Storage & stability · 1 Jun 2026 · 3 likes Worth stating the null on Mean kinetic temperature before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does not get…